Posaconazole therapeutic drug monitoring in pediatrics: a single-center retrospective study.
Publicado: 2026-05-11
BMC pediatrics
MediLens Indexado: 2026-05-12
This study assessed posaconazole therapeutic targets in immunosuppressed pediatric patients. It found that among 42 patients, the mean initial trough concentration was 1.4 ± 1.3 mg/L, with 59.5% achieving therapeutic levels. Adverse events occurred in 23.8% of patients. These findings highlight t...
Leer en PubMed